Hospital Militar Central

Buenos Aires C1426BOR

1 studies enrolling now · 3 studies all time

What they study most

Diffuse Cutaneous Systemic Sclerosis, Gaucher Disease Type 1, Melanoma, Metastases

Studies at this site

• A Gaucher Disease Gene Therapy Trial With FLT201 — Recruiting now
• Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc) — Withdrawn before enrolling
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed